SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-041653
Filing Date
2021-08-05
Accepted
2021-08-05 16:38:47
Documents
72
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q algs-10q_20210630.htm   iXBRL 10-Q 3195803
2 EX-10.1 algs-ex101_268.htm EX-10.1 66962
3 EX-31.1 algs-ex311_9.htm EX-31.1 18045
4 EX-31.2 algs-ex312_6.htm EX-31.2 18057
5 EX-32.1 algs-ex321_11.htm EX-32.1 8516
6 EX-32.2 algs-ex322_10.htm EX-32.2 8524
  Complete submission text file 0001564590-21-041653.txt   9754857

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA algs-20210630.xsd EX-101.SCH 57215
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE algs-20210630_cal.xml EX-101.CAL 50899
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE algs-20210630_def.xml EX-101.DEF 182558
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE algs-20210630_lab.xml EX-101.LAB 478217
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE algs-20210630_pre.xml EX-101.PRE 353808
12 EXTRACTED XBRL INSTANCE DOCUMENT algs-10q_20210630_htm.xml XML 1679351
Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Filer) CIK: 0001799448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39617 | Film No.: 211148984
SIC: 2836 Biological Products, (No Diagnostic Substances)